Organization | Aga Khan University

Aga Khan University Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Karachi Sindh Pakistan (1983)

Organization Overview

First Clinical Trial

2001

NCT00125047

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Aga Khan Health Services | Aga Khan Univeristy | Aga Khan University | Aga Khan University and Hospital | Aga Khan University Hospital | Aga Khan University HOSPITAL | Aga Khan University Hospital Karachi | Aga Khan University Hospital, Karachi | Aga Khan University Hospital, Pakistan | Aga Khan University Hospital, Pakistan (AKU) | Aga khan University, Karachi | Aga Khan University, Karachi | Aga Khan University - World Health Organization | AKU | Associate Professor, Department of Medicine, Aga Khan University | Chairman Department of Medicine, Aga Khan University Hospital | Department of Pediatrics, Aga Khan University | Dr Saara (Ahmad) Muddasir Khan | Mir Asghar Ali Khan, MBA, MPhil | The Aga Khan University | The Aga Khan University Hospital | The Aga Khan University Hospital, Karachi, Pakistan | Women and Child Health Division, Aga Khan University

Active Ingredients

Drugs in Phase 4 Trials (34)

acetaminophen (tylenol) (2 trials)

acetylsalicylic acid (aspirin) (2 trials)

bivalent oral polio vaccine (bopv), type 1 and type 3 (5 trials)

carvedilol (coreg) (2 trials)

chlorhexidine (hibitane) (3 trials)

dexamethasone (1 trial)

dexmedetomidine (precedex) (1 trial)

empagliflozin (jardiance) (1 trial)

human rotavirus, live attenuated (Rotarix) (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

ketamine (ketalar) (1 trial)

lactulose (cephulac) (2 trials)

lidocaine (xylocaine) (5 trials)

metilcelulosa (1 trial)

metronidazole (flagyl) (1 trial)

midazolam (versed) (1 trial)

octreotide (sandostatin) (1 trial)

ondansetron (zofran) (2 trials)

pioglitazone (actos) (1 trial)

poliovirus vaccine inactivated (3 trials)

polyethylene glycol (1 trial)

potassium chloride (klor-con) (1 trial)

procaine benzylpenicillin (novocaine) (6 trials)

ribavirin (virazole) (2 trials)

rituximab (rituxan) (1 trial)

ropivacaine (naropin) (2 trials)

saccharomyces boulardii (2 trials)

sodium chloride (4 trials)

sucrose (1 trial)

terlipressin (3 trials)

tramadol (Ultram) (3 trials)

typhoid vi polysaccharide vaccine (Typhim Vi) (1 trial)

Drugs in Phase 3 Trials (30)

amantadine (symmetrel) (1 trial)

amlodipine (norvasc) (1 trial)

arginine (1 trial)

azithromycin (zithromax) (5 trials)

bovine lactoferrin (2 trials)

ceftriaxone (rocephin) (1 trial)

cephalexin (keflex) (1 trial)

cotrimoxazole (1 trial)

deferasirox (exjade) (1 trial)

deferiprone (ferriprox) (1 trial)

deferoxamine (desferal) (1 trial)

fentanyl (Innovar) (1 trial)

folic acid (2 trials)

gabapentin (neurontin) (1 trial)

gentamicin (garamycin) (2 trials)

interferon gamma-1b (actimmune) (1 trial)

iron (3 trials)

isoflurane (forane) (1 trial)

lactobacillus rhamnosus (1 trial)

mebendazole (vermox) (1 trial)

misoprostol (cytotec) (5 trials)

multivitamins (1 trial)

ornithine aspartate (1 trial)

oxytocin (syntocinon) (1 trial)

pregabalin (lyrica) (1 trial)

propofol (diprivan) (1 trial)

sodium fluoride (1 trial)

vitamin c (1 trial)

vitamin d3 (7 trials)

Drugs in Phase 2 Trials (8)

ad5-ncov (1 trial)

capecitabine (xeloda) (1 trial)

chadox1 (1 trial)

diclofenac (voltaren) (2 trials)

ezetimibe (zetia) (1 trial)

inactivated covid-19 vaccine (1 trial)

nigella sativa (1 trial)

vitamin e (1 trial)

Drugs in Other Trials (29)

acetylcysteine (mucomyst) (1 trial)

ajwa date (1 trial)

Bismuth Subcitrate Potassium (Pylera) (1 trial)

chamomile (1 trial)

choline bitartrate (1 trial)

clarithromycin (biaxin) (1 trial)

clavulanate (Augmentin) (1 trial)

COVID-19 convalescent plasma (1 trial)

epoprostenol (veletri) (1 trial)

esomeprazole (nexium) (1 trial)

furazolidone (furoxone) (1 trial)

hydroxocobalamin (cyanokit) (1 trial)

ibuprofen (motrin) (1 trial)

itropride (1 trial)

levobupivacaine (chirocaine) (2 trials)

magnesium sulfate (Tis-U-Sol) (1 trial)

methyldopa (aldomet) (1 trial)

monovalent oral polio vaccines (mopv1) (2 trials)

nicotinamide (1 trial)

omeprazole (prilosec) (1 trial)

povidone-iodine (1 trial)

prilocaine (citanest) (2 trials)

soybean (1 trial)

tocilizumab (actemra) (1 trial)

vitamin a (1 trial)

wawa mum (1 trial)

wheat flour (1 trial)

whole wheat allergenic extract (1 trial)

zinc dichloride (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Agnosia (Phase 4)

Airway Obstruction (Phase 3)

Anemia (Phase 3)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Bacterial Infections (Phase 3)

Birth Weight (Phase 3)

Brain Diseases (Phase 4)

Brain Neoplasms (Phase 4)

Bronchial Spasm (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Chronic Disease (Phase 4)

Communicable Diseases (Phase 3)

Death (Phase 3)

Dehydration (Phase 4)

Dental Caries (Phase 4)

Dentin Sensitivity (Phase 3)

Diarrhea (Phase 4)

Dyslipidemias (Phase 2)

Enterocolitis (Phase 3)

Enterocolitis, Necrotizing (Phase 3)

Esophageal and Gastric Varices (Phase 4)

Fibrosis (Phase 4)

Gastroenteritis (Phase 4)

Gastrointestinal Hemorrhage (Phase 3)

Gingivitis (Phase 4)

Glucose Intolerance (Phase 3)

Hematemesis (Phase 4)

Hematuria (Phase 2)

Hemorrhage (Phase 4)

Hepatic Encephalopathy (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 3)

Hepatitis C (Phase 4)

Hepatitis D (Phase 2)

Hepatitis D, Chronic (Phase 2)

Hypercholesterolemia (Phase 2)

Hypersensitivity (Phase 3)

Hypertension (Phase 4)

Hypertension, Portal (Phase 4)

Hypokalemia (Phase 4)

Hypospadias (Phase 4)

Infections (Phase 4)

Infertility (Phase 2)

Infertility, Female (Phase 2)

Intervertebral Disc Displacement (Phase 3)

Irritable Bowel Syndrome (Phase 4)

Laryngismus (Phase 3)

Lower Urinary Tract Symptoms (Phase 2)

Malnutrition (Phase 4)

Maternal Death (Phase 3)

Metabolic Syndrome (Phase 2)

Nausea (Phase 4)

Neonatal Sepsis (Phase 3)

Pain, Postoperative (Phase 4)

Paratyphoid Fever (Phase 4)

Perinatal Death (Phase 3)

Periodontitis (Phase 4)

Pneumonia (Phase 3)

Poliomyelitis (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Postpartum Hemorrhage (Phase 3)

Potassium Deficiency (Phase 4)

Pregnancy Complications, Infectious (Phase 3)

Prolapse (Phase 3)

Prostatic Neoplasms (Phase 2)

Puerperal Infection (Phase 3)

Respiratory Aspiration (Phase 4)

Sepsis (Phase 3)

Surgical Wound Infection (Phase 3)

Syndrome (Phase 4)

Tachypnea (Phase 4)

Thalassemia (Phase 3)

Toxemia (Phase 3)

Typhoid Fever (Phase 4)

Vitamin D Deficiency (Phase 3)

Vomiting (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 104
# of Trial APIs: 101